## **Core Concept**
The question tests the understanding of metastatic bone disease, specifically the types of cancers that lead to osteoblastic (bone-forming) metastases. Osteoblastic metastases are characterized by increased bone density due to excessive bone formation. This is in contrast to osteolytic metastases, which involve bone destruction.

## **Why the Correct Answer is Right**
Prostate cancer is well-known for causing osteoblastic metastases. The mechanism involves the secretion of factors by prostate cancer cells that stimulate osteoblasts, leading to increased bone formation. One of the key factors involved is **endothelin-1**, which is overexpressed in prostate cancer and has potent vasoconstrictive and mitogenic effects on osteoblasts. Additionally, prostate cancer cells can produce **bone morphogenetic proteins (BMPs)** and other growth factors that promote osteoblastic activity.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While breast cancer can cause both osteolytic and osteoblastic metastases, it is more commonly associated with osteolytic lesions. The mixed pattern can occur, but it is not predominantly osteoblastic.
- **Option B:** Lung cancer typically causes osteolytic metastases. Although it can lead to a mixed pattern, osteolysis is more characteristic.
- **Option C:** This option seems to be missing, but based on common metastatic patterns, one might expect gastrointestinal or other cancers here, which are less commonly associated with osteoblastic metastases compared to prostate cancer.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **prostate-specific antigen (PSA) levels** can be elevated in patients with prostate cancer metastases to bone, even in the absence of local recurrence. This is because prostate cancer cells can metastasize to bone and continue to produce PSA.

## **Correct Answer:** . Prostate carcinoma.